language_icon
EN
HI

Torrent Pharmaceuticals Share price

TORNTPHARM

4185.1

0.00 (0.00%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:41 IST
Today's High

4234.70

Today's Low

4146.10

52 Week Low

3101.60

52 Week High

4482.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Torrent Pharmaceuticals Chart

Torrent Pharmaceuticals Share Key Metrics

Volume
2.78 L
Market Cap
141642.80 CR
LTQ@LTP
1@4185.10
ATP
4181.59
Var Margin
12.5 %
Circuit Range
3808.4-4654.6
Delivery %
57.12 %
Value
116.27 CR
ASM/GSM
No
Market Lot
1

Summary

Torrent Pharmaceuticals share price stands at ₹4185.1 at 30 Apr, 2026 | 15:41. The stock Torrent Pharmaceuticals intraday movement has stayed between ₹4146.10 and ₹4234.70, while on a 52-week basis it has fluctuated from ₹3101.60 to ₹4482.90.
In terms of trading activity, Torrent Pharmaceuticals has recorded a volume of 278059 shares. The Torrent Pharmaceuticals has a market cap of ₹338445440. The stock’s Average Traded Price (ATP) stands at ₹418159, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 418510.
The Torrent Pharmaceuticals operates within a circuit range of ₹3808.4-4654.6 – ₹3808.4-4654.6, with a Value of ₹116.27 CR. The Delivery Percentage for the day is 57.12%. Additionally, Torrent Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Torrent Pharmaceuticals Fundamentals

View More
P/E Ratio

62.44

P/B Ratio

15.62

Div. Yield

0.76

Sector P/E

65.48

Sector P/B

3.51

Sec. Div. Yield

0.57

Torrent Pharmaceuticals Resistance and Support

Pivot 4188.63

Resistance

First Resistance

4231.16

Second Resistance

4277.23

Third Resistance

4319.76

Support

First Support

4142.56

Second Support

4100.03

Third Support

4053.96

Torrent Pharmaceuticals Futures & Options

link_white_icon

Torrent Pharmaceuticals Option Chain

View Price, OI, Greeks & More...
View All

26MAY26

4205.10

1.60 (0.04%)

30JUN26

4220.30

9.40 (0.22%)

28JUL26

4190.20

0.00 (0.00%)

TORNTPHARM|26MAY26 CE 4150.00

149.20

-1.05 (-0.7%)

TORNTPHARM|26MAY26 PE 4200.00

116.15

-2.55 (-2.15%)

Torrent Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
  • 2019-20
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

71.25%

Mutual Fund

4.48%

Insurance

1.96%

Foreign Institutional Investors

14.08%

Domestic Institutional Investors

0.78%

Retail

7.45%

Others

0%

Total Promoters
MAR '23
71.25%
JUN '23
71.25%
SEP '23
71.25%
DEC '23
71.25%

Torrent Pharmaceuticals Corporate Actions

DateAgenda
2026-02-13Quarterly Results & Interim Dividend
2026-01-05Others
2025-11-07Quarterly Results
2025-07-28Quarterly Results & Others
2025-05-20Audited Results
2025-01-24Quarterly Results & Others

Torrent Pharmaceuticals News

Torrent Pharmaceuticals Limited

Torrent Pharma shareholders have approved the Scheme of Amalgamation with J.B. Chemicals & Pharmaceuticals Limited at a meeting held on April 28, 2026. This approval is a key step towards completing the merger.
Apr 28 2026 22:04:00

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals shareholders approved the scheme of amalgamation with J. B. Chemicals & Pharmaceuticals Limited. The approval was passed by a requisite majority at the NCLT convened meeting held on April 28, 2026.
Apr 28 2026 22:04:00

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals' equity shareholders approved the scheme of amalgamation with J. B. Chemicals & Pharmaceuticals Limited. This approval was obtained in an NCLT-convened meeting with the requisite majority, allowing the merger to proceed as planned.
Apr 28 2026 21:04:00

Torrent Pharmaceuticals Ltd - 500420 - Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting

Torrent Pharma's equity shareholders have approved the proposed Scheme of Amalgamation with J. B. Chemicals & Pharmaceuticals Limited (JB Pharma). The approval was granted with the requisite majority at the NCLT-convened meeting held on April 28, 2026, marking a significant step in the merger process.
Apr 28 2026 21:04:00

Torrent Pharmaceuticals Limited

Torrent Pharma filed a disclosure regarding post-listing non-convertible debentures (NCDs) in compliance with SEBI regulations. The filing provides comprehensive details of NCDs issued and outstanding as of March 31, 2026, and confirms no default history in debt servicing.
Apr 23 2026 19:04:00

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals disclosed details of listed debt securities issued through private placement for the half year ended March 31, 2026. The disclosure includes approximately ₹10,990 crore in outstanding NCDs across four issuances with coupon rates up to 7.80%, and confirmed the redemption of NCDs (ISIN INE685A07082) on December 12, 2025.
Apr 15 2026 11:04:00

Torrent Pharmaceuticals Limited

Torrent Pharma's Bileshwarpura (Oncology) facility underwent a USFDA inspection from April 6-10, 2026. The inspection concluded with zero observations, indicating compliance with regulatory standards.
Apr 10 2026 19:04:00

Torrent Pharmaceuticals Ltd - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Torrent Pharma's Bileshwarpura (Oncology) facility underwent a USFDA inspection from 06-Apr-26 to 10-Apr-26. The inspection concluded successfully with zero observations, indicating high compliance standards.
Apr 10 2026 19:04:00

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals confirmed the full utilization of Commercial Papers proceeds by March 31, 2026. This utilization was in line with the purpose disclosed in the Disclosure Document and adhered to SEBI regulations.
Apr 06 2026 17:04:00
Read More

About Torrent Pharmaceuticals

NSE : 3518  
BSE : 500420  
ISIN : INE685A01028  

Torrent Pharmaceuticals Management

NamePosition
Samir MehtaChairman
Ameera ShahNon Executive Independent Director
View More

Torrent Pharmaceuticals FAQs

The Buying Price of Torrent Pharmaceuticals share is 4185.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Torrent Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Torrent Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Torrent Pharmaceuticals shares is 62.44. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Torrent Pharmaceuticals shares is 15.62. Useful to assess the stock's value relative to its book value.

To assess Torrent Pharmaceuticals’s valuation compare Sector P/E, P/B which are 65.48 & 3.51 with sector averages, along with growth rates and financial metrics.

The Market Cap of Torrent Pharmaceuticals is 141642.80 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Torrent Pharmaceuticals share price is 4482.90 & 3101.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Torrent Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost